日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CRISPR screen reveals a simultaneous targeted mechanism to reduce cancer cell selenium and increase lipid oxidation to induce ferroptosis.

CRISPR筛选揭示了一种同时靶向降低癌细胞硒含量和增加脂质氧化以诱导铁死亡的机制

Lamperis Sophia M, McMahon Kaylin M, Calvert Andrea E, Rink Jonathan S, Vasan Karthik, Pandkar Madhura R, Crentsil Eliana U, Chalmers Zachary R, McDonald Natalie R, Kosmala Cameron J, Bonini Marcelo G, Matei Daniela, Gordon Leo I, Chandel Navdeep S, Thaxton C Shad

Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression

癌代谢物乳酸通过调节组蛋白乳酸化依赖性 c-Myc 表达来促进乳腺癌进展

Madhura R Pandkar, Sommya Sinha, Atul Samaiya, Sanjeev Shukla

PKM2 dictates the poised chromatin state of PFKFB3 promoter to enhance breast cancer progression

PKM2 控制 PFKFB3 启动子的染色质平衡状态,从而促进乳腺癌进展

Madhura R Pandkar, Adarsh Raveendran, Kajal Biswas, Srinivas Abhishek Mutnuru, Jharna Mishra, Atul Samaiya, Tyler Malys, Alexander Y Mitrophanov, Shyam K Sharan, Sanjeev Shukla

Pathophysiology of Covid-19 and host centric approaches in Ayurveda

新冠肺炎的病理生理学及阿育吠陀中的宿主中心疗法

Pandkar, Prasad Dilip; Sachdeva, Vinay

Efficacy of Madhav Rasayan Plus as adjuvant in moderate COVID-19 patients: Preliminary outcomes of randomized controlled trial

Madhav Rasayan Plus 作为辅助疗法治疗中度 COVID-19 患者的疗效:随机对照试验的初步结果

Jamadagni, Sameer; Pandkar, Prasad; Saundankar, Tushar; Shirke, Girish; Malekar, Shailesh; Vaidya, V G

COVID-19 patient with B cell lymphoma co-morbidity managed with co-administration of ayurvedic formulation

一名合并B细胞淋巴瘤的新冠肺炎患者,通过同时服用阿育吠陀配方进行治疗。

Dilip Pandkar, Prasad; Deshmukh, Santosh Raosaheb; Sachdeva, Vinay

Hypoxia-induced TGF-β-RBFOX2-ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer

缺氧诱导的TGF-β-RBFOX2-ESRP1轴调控人MENA选择性剪接并促进乳腺癌EMT

Neha Ahuja,Cheemala Ashok,Subhashis Natua,Deepak Pant,Anna Cherian,Madhura R Pandkar,Pooja Yadav,Narayanan S S Vishnu,Jharna Mishra,Atul Samaiya,Sanjeev Shukla